Presentations -
-
Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients International conference
Honda Takashi, Ishigami Masatoshi, Ito Takanori, Ishizu Yoji, Kuzuya Teiji, Hirooka Yoshiki
AASLD2018 2018.10
-
インターフェロン治療によるHBV core I97L変異の 誘導とHBV DNA及びHBsAg減少率に関する検討
本多 隆、石上雅敏、後藤秀実
第54回日本肝臓学会総会 2018.6.14
-
C型肝炎ウイルスの肝病態による腸内細菌叢の違いと駆除後の肝癌発症との関連
本多 隆、石上雅敏、廣岡芳樹
肝臓学会総会 2018.6.14
-
C型肝炎による肝発癌に関連する腸内細菌叢の検討
本多 隆、廣岡芳樹、後藤秀実
消化器病学会総会 2018.4.20
-
Naturally occurring drug resitance substitutions in the NS5A and NS5B regions in Hepatitis C virus genotype 2 and response to sofosbuvir plus ribavirin therapy International conference
Hayashi K., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Utility and limitation of non-invasive fibrosis markers for predicting the prognosis in biopsy-proven Japanese NAFLD patients International conference
Ito T., Ishigami M., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Secreted ectodomain of SIGLEC-9 and MCP-1 ameliorate acute liver failure in rats by altering bone marrow macrophage polarity International conference
Ito T., Ishigami M., Yamamoto A., Ishizu Y., Kazuya T., Honda T., Hayashi K., Ishikawa T., Hirooka Y., Goto H.
EASL2018 2018.4
-
Prognostic factors related to post-progression survival in advanced hepatocellular carcinoma patients treated with sorafenib not eligible for second-line regorafenib treatment Teiji Kuzuya* 1, Masatoshi Ishigami1, Takanori Ito1, Yoji Ishizu1"
Kuzuya T, Ishigami M, Ito T, Ishizu Y, Honda T, Hirooka Y
ILCA2018 2018
-
Association between microbiome and hepatitis C virus-infected patients with hepatocellular carcinoma International conference
Honda T, Ishigami M, Yamamoto K, Ito T, Ishizu Y, Kuzuya T, Hirooka Y
ILCA2018 2018
-
Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data International conference
Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Ishikawa Tetsuya, Nakano Isao, Urano Fumihiro, Kumada Takashi, Yoshioka Kentaro, Goto Hidemi, Hirooka Yoshiki
APASL 2017.11
-
B型慢性肝炎におけるインターフェロン治療効果とcoreI97L変異によるその後の肝炎沈静化の予測
本多隆、石上雅敏、後藤秀実
JDDW2017 2017.10.12
-
非B非C肝癌における肝発癌に関連する腸内細菌叢の検討
本多隆
JDDW2017 2017.10.12
-
Core I97LとP79Qの変異はB型慢性肝炎患者において持続HBVDNA低値とHBs抗原消失に関与する
本多 隆、石上雅敏、後藤秀実
第53回日本肝臓学会総会 2017.6.8
-
The Impact of Hepatitis B Virus Infection on Sustained Virologic Response and HBV Reactivation in Patients with Chronic Hepatitis C who Treated by all-Oral Direct-Acting Antivirals Regimens International conference
Hayashi K, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hirooka Y, Goto H
DDW2017 2017
-
The Association Between Amino Acid Substitutions in the NS5A Region of Hepatitis C Virus and Development of Hepatocellular Carcinoma After Sustained Virological Response International conference
Yashuda S, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Hirooka Y, Goto H"
DDW2017 2017
-
B型慢性肝炎におけるインターフェロン治療効果とCoreI97L変異による治療効果の予測
本多隆
JDDW2016 2016.11.2
-
Relation between core mutations and HBVDNA, HBsAg decreasing rate in the patients with chronic hepatitis B International conference
Takashi Honda
APDDW2016 2016.11.2
-
Revisiting the prognosis after liver transplantation in HCV-positive patients-focus on HCV-unrelated complications International conference
Ishigami Masatoshi, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Ishizu Yoji, Hirooka Yoshiki, Goto Hidemi
APASL2016 2016.11
-
Treatment for elderly patients with hepatitis C Invited International conference
Takashi Honda, Masatoshi Ishigami, Kazuhiko Hayashi, Hidemi Goto
3rd International Monothematic Conference on Viral Hepatitis C 2016.9.29
-
コリン欠乏高脂肪食によるNASHマウスモデルにおける分岐鎖アミノ酸投与による糖質、アミノ酸代謝の変化
本多 隆、石上雅敏、山本健太、安藤祐資、安田 諭、伊藤隆徳、野村 彩、加藤幸一郎、新家卓郎、石津洋二、葛谷貞二、林 和彦、廣岡芳樹、石川哲也、中野功、後藤秀実
第3回肝臓と糖尿病代謝研究会 2016.7.16